Femasys (FEMY) Research & Development (2020 - 2026)
Femasys (FEMY) posted Research & Development of $1.95 million for Q2 2026, up 37.6% from $1.41 million a year earlier.
Powered by 
Analysis
Femasys (FEMY) Research & Development (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Femasys was $8.5 million, down 4.0% year-over-year; for FY2025, it came in at $7.58 million, down 7.8% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 12.9% (FY2020 to FY2025).
- In prior years, Femasys' Research & Development was $8.22 million in FY2024 (+14.0%), $7.21 million in FY2023 (+24.0%), $5.81 million in FY2022 (+42.3%) and $4.08 million in FY2021 (-1.1%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q1 2025.
- On a year-over-year basis, Research & Development increased in four of the last five quarters, with growth averaging 18.5%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q1 2025, with growth of 67.6%; the weakest was Q2 2025, with a decline of 28.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 278.90 Mn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 258.00 Mn |
| 10 | Femasys | 6.32 Mn | -14.34 Mn | 189,391.00 | 1.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 894,868.00 |
| Mar 31, 2021 | 995,022.00 |
| Dec 31, 2020 | 895,591.00 |
API Access
Femasys Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=FEMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "FEMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=FEMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();